Work

Immuno-oncology (IO) combinations +/- VEGF targeted therapy (VEGF TT) in patients (pts) with advanced mit family translocation renal cell carcinomas (tRCC): Results from an international multicenter study.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.343

Authors: Omar Alhalabi, Jonathan Thouvenin, Sylvie Negrier, Yann-Alexandre Vano, Luca Campedel, Elshad Hasanov, Ziad Bakouny, Andrew Warren Hahn, Mehmet Asim Bilen, Toni K. Choueiri, Srinivas Raghavan Viswanathan, Kanishka Sircar, Laurence Albiges, Gabriel Malouf, Nizar M. Tannir

Institutions: The University of Texas MD Anderson Cancer Center, Institut de Cancérologie Strasbourg, Lyon 1 Université, Centre Léon Bérard, Université Paris Descartes, Pitié-Salpêtrière Hospital, Université Pierre-et-Marie-Curie, Dana-Farber Cancer Institute, Emory University, Université Paris-Saclay, Institut Gustave Roussy

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4213301949

Cites:

Cited by: 3

Related to: 10